Xiangxue Pharmaceutical Co.,Ltd.
SZSE:300147.SZ
5.12 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||||||
| Current Assets: | |||||||||||||||||
| Cash & Cash Equivalents
| 149.317 | 166.503 | 196.122 | 605.136 | 495.694 | 650.107 | 1,413.791 | 835.787 | 657.333 | 334.412 | 761.209 | 1,289.427 | 785.986 | 1,152.254 | 89.083 | 40.072 | 44.473 |
| Short Term Investments
| -40.872 | 0.126 | 65.626 | 19.337 | 28.544 | 23.337 | -16.171 | 26.364 | 21.274 | -6.457 | 0 | 0 | 0.204 | 0.204 | 0.206 | 0.285 | 0.483 |
| Cash and Short Term Investments
| 149.317 | 166.629 | 261.748 | 624.473 | 524.238 | 673.444 | 1,413.791 | 862.151 | 678.607 | 334.412 | 761.209 | 1,289.427 | 785.986 | 1,152.254 | 89.083 | 40.072 | 44.473 |
| Net Receivables
| 1,195.279 | 971.3 | 1,841.427 | 2,147.442 | 1,748.276 | 2,095.343 | 2,521.828 | 1,222.838 | 775.953 | 622.121 | 502.434 | 288.895 | 184.504 | 135.047 | 104.974 | 55.077 | 38.81 |
| Inventory
| 411.298 | 467.075 | 761.464 | 839.81 | 756.406 | 590.062 | 504.547 | 503.133 | 341.75 | 284.296 | 224.592 | 128.726 | 89.353 | 54.222 | 30.243 | 23.604 | 19.817 |
| Other Current Assets
| 68.45 | 88.183 | 221.364 | 108.996 | 70.909 | 559.736 | 632.213 | 392.688 | 331.265 | 7.495 | 9.423 | -15.102 | -11.344 | -6.182 | -5.575 | -3.246 | -1.917 |
| Total Current Assets
| 1,824.344 | 1,693.187 | 3,086.002 | 3,720.721 | 3,099.83 | 3,918.586 | 5,072.38 | 2,980.809 | 2,127.574 | 1,248.325 | 1,497.658 | 1,691.947 | 1,048.498 | 1,335.34 | 218.725 | 115.507 | 101.184 |
| Non-Current Assets: | |||||||||||||||||
| Property, Plant & Equipment, Net
| 4,619.947 | 5,525.483 | 5,955.784 | 3,488.702 | 3,293.122 | 2,682.988 | 2,362.624 | 2,865.608 | 1,620.878 | 1,481.557 | 1,303.353 | 1,027.429 | 687.662 | 440.319 | 405.611 | 358.768 | 401.127 |
| Goodwill
| 199.72 | 199.72 | 266.597 | 626.61 | 626.61 | 644.667 | 646.661 | 634.536 | 422.528 | 422.528 | 423.704 | 66.679 | 66.679 | 1.216 | 1.258 | 1.291 | 1.37 |
| Intangible Assets
| 1,355.777 | 1,367.021 | 1,429.77 | 973.961 | 721.627 | 778.351 | 559.822 | 401.167 | 301.952 | 238.011 | 219.588 | 157.823 | 113.959 | 67.38 | 70.281 | 73.153 | 47.072 |
| Goodwill and Intangible Assets
| 1,555.497 | 1,566.741 | 1,696.366 | 1,600.572 | 1,348.237 | 1,423.018 | 1,206.482 | 1,035.703 | 724.48 | 660.539 | 643.292 | 224.502 | 180.638 | 68.596 | 71.539 | 74.443 | 48.442 |
| Long Term Investments
| 219.35 | 471.904 | 204.585 | 423.665 | 412.481 | 342.856 | 351.062 | 243.246 | 135.884 | 174.925 | 17.798 | 0.204 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 28.416 | 26.306 | 19.373 | 21.225 | 39.784 | 31.449 | 27.005 | 18.346 | 8.413 | 6.769 | 7.612 | 3.113 | 2.968 | 0.955 | 0.974 | 1.161 | 0.845 |
| Other Non-Current Assets
| 33.076 | 69.38 | 418.482 | 523.285 | 268.21 | 226.712 | 421.134 | 845.015 | 34.774 | 16.169 | 4.995 | 1.837 | 1.371 | 1.418 | 1.466 | 1.592 | 1.836 |
| Total Non-Current Assets
| 6,456.286 | 7,659.813 | 8,294.59 | 6,057.449 | 5,361.834 | 4,707.023 | 4,368.307 | 5,007.918 | 2,524.428 | 2,339.959 | 1,977.05 | 1,257.085 | 872.64 | 511.287 | 479.59 | 435.964 | 452.249 |
| Total Assets
| 8,280.63 | 9,353.001 | 11,380.592 | 9,778.169 | 8,461.663 | 8,625.609 | 9,440.687 | 7,988.727 | 4,652.002 | 3,588.283 | 3,474.708 | 2,949.032 | 1,921.138 | 1,846.628 | 698.315 | 551.471 | 553.433 |
| Liabilities & Equity: | |||||||||||||||||
| Current Liabilities: | |||||||||||||||||
| Account Payables
| 1,087.241 | 841.313 | 1,122.753 | 801.001 | 707.721 | 451.436 | 461.056 | 517.604 | 238.909 | 250.067 | 221.308 | 110.271 | 79.357 | 79.182 | 76.182 | 118.724 | 39.26 |
| Short Term Debt
| 1,842.028 | 2,006.057 | 2,916.799 | 3,015.331 | 1,744.058 | 2,316 | 1,649.381 | 1,595.055 | 42 | 635 | 414 | 514 | 152.5 | 260 | 140.5 | 94 | 50.9 |
| Tax Payables
| 70.627 | 33.597 | 31.945 | 33.808 | 35.03 | 23.267 | 36.216 | 31.922 | 25.086 | 20.041 | 26.092 | 22.778 | 14.719 | 19.032 | 16.347 | 9.565 | 9.321 |
| Deferred Revenue
| 2,165.17 | 249.785 | 2,889.465 | 553.856 | 745.215 | 23.267 | 496.422 | 402.965 | 249.58 | 221.34 | 358.982 | 62.536 | 46.009 | 43.401 | 35.068 | 32.878 | 25.936 |
| Other Current Liabilities
| 67.242 | 2,755.401 | 15.281 | 9.84 | 66.114 | 431.734 | 828.606 | 785.515 | 33.369 | 30.942 | 23.876 | 20.51 | 16.551 | 21.213 | 39.771 | 20.384 | 20.348 |
| Total Current Liabilities
| 5,161.682 | 5,852.556 | 6,944.299 | 4,380.027 | 3,263.107 | 3,222.436 | 3,435.466 | 3,301.139 | 563.858 | 1,137.349 | 1,018.166 | 707.316 | 294.418 | 403.796 | 291.52 | 265.986 | 136.444 |
| Non-Current Liabilities: | |||||||||||||||||
| Long Term Debt
| 590.919 | 451.85 | 531.281 | 946.915 | 938.205 | 1,308.419 | 1,821.696 | 754 | 498.975 | 536.895 | 715.815 | 674.735 | 180 | 42.5 | 42.5 | 62.5 | 87.5 |
| Deferred Revenue Non-Current
| 60.425 | 60.352 | 65.649 | 75.661 | 85.971 | 58.557 | 64.043 | 49.234 | 43.189 | 42.832 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 9.462 | 0 | 3.727 | 0.023 | -875.477 | 14.521 | -1,585.946 | -554 | -498.975 | -536.895 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 144.925 | 170.06 | 77.858 | 122.508 | 938.205 | 9.407 | 1,821.696 | 754 | 498.975 | 536.895 | 30.718 | 30.415 | 27.743 | 29.714 | 26.67 | 26.45 | 138.039 |
| Total Non-Current Liabilities
| 805.731 | 682.263 | 678.516 | 1,145.108 | 1,086.904 | 1,390.904 | 2,121.489 | 1,003.234 | 542.164 | 579.727 | 746.533 | 705.15 | 207.743 | 72.214 | 69.17 | 88.95 | 225.539 |
| Total Liabilities
| 5,967.412 | 6,534.819 | 7,622.814 | 5,525.135 | 4,350.012 | 4,613.34 | 5,556.955 | 4,304.373 | 1,106.022 | 1,717.076 | 1,764.699 | 1,412.466 | 502.16 | 476.01 | 360.69 | 354.936 | 361.983 |
| Equity: | |||||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.641 | 1.225 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 661.279 | 661.279 | 661.361 | 661.476 | 661.476 | 661.476 | 661.476 | 661.476 | 661.476 | 509.573 | 392.055 | 300.973 | 246 | 123 | 92 | 81 | 81 |
| Retained Earnings
| -987.434 | -500.117 | 33.042 | 720.361 | 699.951 | 610.421 | 573.822 | 509.412 | 529.443 | 431.77 | 309.965 | 222.571 | 173.693 | 135.23 | 118.609 | 72.715 | 72.757 |
| Accumulated Other Comprehensive Income/Loss
| 1.693 | 100.529 | 116.821 | 109.926 | 65.095 | 91.73 | 92.628 | 91.73 | 82.789 | -3.641 | -1.225 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 2,249.163 | 2,143.441 | 2,134.328 | 2,124.773 | 2,061.891 | 2,066.964 | 2,133.977 | 2,133.977 | 2,133.977 | 802.549 | 903.416 | 959.775 | 974.445 | 1,089.409 | 109.936 | 28.381 | 25.181 |
| Total Shareholders Equity
| 1,924.702 | 2,405.133 | 2,945.553 | 3,616.536 | 3,488.414 | 3,430.591 | 3,461.903 | 3,396.596 | 3,407.686 | 1,743.892 | 1,605.437 | 1,483.319 | 1,394.138 | 1,347.639 | 320.545 | 182.096 | 178.937 |
| Total Equity
| 2,313.218 | 2,818.182 | 3,757.778 | 4,253.034 | 4,111.652 | 4,012.269 | 3,883.732 | 3,684.354 | 3,545.98 | 1,871.207 | 1,710.009 | 1,536.565 | 1,418.978 | 1,370.618 | 337.625 | 196.535 | 191.449 |
| Total Liabilities & Shareholders Equity
| 8,280.63 | 9,353.001 | 11,380.592 | 9,778.169 | 8,461.663 | 8,625.609 | 9,440.687 | 7,988.727 | 4,652.002 | 3,588.283 | 3,474.708 | 2,949.032 | 1,921.138 | 1,846.628 | 698.315 | 551.471 | 553.433 |